Socioeconomic impact of high-cost drugs in Brazilian dermatology. Legal and financial aspects, and impact on clinical practice
de Oliveira, Renan Tironi Giglio; Agostinho, Giovana Larissa Prado Leite; Granja, Rubens; Oyafuso, Luiza Keiko M.; Criado, Paulo Ricardo
An. Bras. Dermatol.
DATA DE PUBLICAÇÃO
Abstract The technological advancement of the pharmaceutical industry, resulting from the techniques of molecular biology and expansion of the knowledge of immunopathogenesis, has modified the therapeutic arsenal used in dermatology. Scientific research and regulatory standards cause drug costs to rise, thus making their use impossible in most public policies. In order to make high-cost drugs viable in the public health network, the Specialized Pharmaceutical Assistance Component was created. However, despite the frequent incorporation of medications, the constant requirement of drugs through lawsuits leads to exorbitant costs to the state budget. The present work analyzed through a descriptive observational study, the current situation of the Specialized Component and the involvement of medicines used in dermatology, through legal reviews, financial analyses, and medical articles, aiming at future incorporations for the specialty. When assessing the legal demands for dermatological drugs in the state of São Paulo, the specialty still has a low participation and psoriasis is the main disease involved in requiring drugs through the judicial system in the state. New methods of access to raw materials must be created to reduce legal issues. Cost-effectiveness and public planning studies are mandatory for incorporating new dermatological therapies.
- Level of satisfaction of clients of public pharmacies dispensing high-cost drugs in Espírito Santo, Brazil
- Application of the principles of evidence-based medicine in programs to assess high-cost procedures and medications
- Exploratory analysis of requests for authorization to dispense high-cost medication to COPD patients: the São Paulo “protocol”
- Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation
- Changes in the Brazilian Annals of Dermatology. Unpostponable initiatives